Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Replication of parvovirus B19 in hematopoietic progenitor cells generated in vitro from normal human peripheral blood.

Literature DB >> 1731104

Replication of parvovirus B19 in hematopoietic progenitor cells generated in vitro from normal human peripheral blood.

T F Schwarz¹, S Serke, B Hottenträger, A von Brunn, H Baurmann, A Kirsch, W Stolz, D Huhn, F Deinhardt, M Roggendorf.

Abstract

Erythroid progenitor cells generated in vitro from peripheral human blood in the presence of interleukin-3 and erythropoietin were infected with human parvovirus B19. B19 virus DNA replication was highest 48 to 72 h after infection, and maximum levels of B19 virus proteins were detected in culture supernatants at 72 to 96 h after infection. B19 virus propagated in vitro was infectious. This cell culture system with peripheral blood cells facilitates studies in vitro of B19 virus replication.

Entities: Gene Species

Mesh：

Substances：
DNA, Viral
Viral Proteins

Year: 1992 PMID： 1731104 PMCID： PMC240841

Source DB: PubMed Journal: J Virol ISSN： 0022-538X Impact factor: 5.103

22 in total

1. A liquid culture method for the in vitro growth of hemopoietic progenitor cells from normal human adult peripheral blood allowing for analysis by multiparameter flow-cytometry.

Authors: S Serke; S Säuberlich; D Huhn
Journal: Eur J Haematol Date: 1991-02 Impact factor: 2.997

2. Parvovirus B19 infection of the fetus. Histology and in situ hybridization.

Authors: T F Schwarz; A Nerlich; B Hottenträger; G Jäger; I Wiest; S Kantimm; H Roggendorf; M Schultz; K P Gloning; T Schramm
Journal: Am J Clin Pathol Date: 1991-07 Impact factor: 2.493

3. Immunoglobulins in the prophylaxis of parvovirus B19 infection.

Authors: T F Schwarz; M Roggendorf; B Hottenträger; S Modrow; F Deinhardt; J Middeldorp
Journal: J Infect Dis Date: 1990-11 Impact factor: 5.226

4. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.

Authors: N Frickhofen; J L Abkowitz; M Safford; J M Berry; J Antunez-de-Mayolo; A Astrow; R Cohen; I Halperin; L King; D Mintzer
Journal: Ann Intern Med Date: 1990-12-15 Impact factor: 25.391

5. Human parvovirus B19: ELISA and immunoblot assays.

Authors: T F Schwarz; M Roggendorf; F Deinhardt
Journal: J Virol Methods Date: 1988-06 Impact factor: 2.014

6. An outbreak of erythema infectiosum associated with human parvovirus infection.

Authors: M J Anderson; E Lewis; I M Kidd; S M Hall; B J Cohen
Journal: J Hyg (Lond) Date: 1984-08

7. Productive infection of in vitro generated haemopoietic progenitor cells from normal human adult peripheral blood with parvovirus B19: studies by morphology, immunocytochemistry, flow-cytometry and DNA-hybridization.

Authors: S Serke; T F Schwarz; H Baurmann; A Kirsch; B Hottenträger; A Von Brunn; M Roggendorf; D Huhn; F Deinhardt
Journal: Br J Haematol Date: 1991-09 Impact factor: 6.998

8. Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV).

Authors: B J Cohen; P P Mortimer; M S Pereira
Journal: J Hyg (Lond) Date: 1983-08

9. Parvovirus-like particles in human sera.

Authors: Y E Cossart; A M Field; B Cant; D Widdows
Journal: Lancet Date: 1975-01-11 Impact factor: 79.321

10. A human parvovirus-like virus inhibits haematopoietic colony formation in vitro.

Authors: P P Mortimer; R K Humphries; J G Moore; R H Purcell; N S Young
Journal: Nature Date: 1983 Mar 31-Apr 6 Impact factor: 49.962

12 in total

Review 1. Pathogenesis of human parvovirus B19 in rheumatic disease.

Authors: J R Kerr
Journal: Ann Rheum Dis Date: 2000-09 Impact factor: 19.103

Review 2. Human Parvovirus B19 and blood product safety: a tale of twenty years of improvements.

Authors: Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giuseppina Facco; Gabriele Calizzani; Fabio Candura; Giancarlo M Liumbruno; Giuliano Grazzini
Journal: Blood Transfus Date: 2015-04 Impact factor: 3.443

Review 3. Human Parvoviruses.

Authors: Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal: Clin Microbiol Rev Date: 2017-01 Impact factor: 26.132

4. Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells.

Authors: K A Weigel-Kelley; M C Yoder; A Srivastava
Journal: J Virol Date: 2001-05 Impact factor: 5.103

Review 5. Parvovirus B19 infection.

Authors: J R Kerr
Journal: Eur J Clin Microbiol Infect Dis Date: 1996-01 Impact factor: 3.267

6. DNA replication of parvovirus B 19 in a human erythroid leukemia cell line (JK-1) in vitro.

Authors: T Takahashi; K Ozawa; K Takahashi; Y Okuno; T Takahashi; Y Muto; F Takaku; S Asano
Journal: Arch Virol Date: 1993 Impact factor: 2.574

7. Erythroid progenitor cells expanded from peripheral blood without mobilization or preselection: molecular characteristics and functional competence.

Authors: Claudia Filippone; Rauli Franssila; Arun Kumar; Leena Saikko; Panu E Kovanen; Maria Söderlund-Venermo; Klaus Hedman
Journal: PLoS One Date: 2010-03-02 Impact factor: 3.240

8. Ex vivo-generated CD36+ erythroid progenitors are highly permissive to human parvovirus B19 replication.

Authors: Susan Wong; Ning Zhi; Claudia Filippone; Keyvan Keyvanfar; Sachiko Kajigaya; Kevin E Brown; Neal S Young
Journal: J Virol Date: 2007-12-26 Impact factor: 5.103

Review 9. Human parvovirus B19.

Authors: Erik D Heegaard; Kevin E Brown
Journal: Clin Microbiol Rev Date: 2002-07 Impact factor: 26.132

10. Successful replication of parvovirus B19 in the human megakaryocytic leukemia cell line MB-02.

Authors: N C Munshi; S Zhou; M J Woody; D A Morgan; A Srivastava
Journal: J Virol Date: 1993-01 Impact factor: 5.103